Results 1 to 10 of about 7,630 (161)
THE DISTRIBUTION OF ANTIBODIES AND THEIR FORMATION BY THE BLOOD [PDF]
In the following we give a brief summary of the principal results that we have obtained from a study of the distribution of antibodies in the body fluids of dogs and of their formation by the blood. The complete article will be published later. In active immunization of dogs by a single intravenous injection of goat blood the lysin, agglutinin and ...
L. Hektoen
openalex +8 more sources
The suppression of antibody formation by passively administered antibody is influenced by the dose and nature of the antigen, type of immunization procedure, ratio of antibody to antigen, species origin and characteristics of the antiserum used, as well as the species selected for immunization.
Jonathan W. Uhr, Joyce B. Baumann
openalex +8 more sources
Comparison of antibody responses after the 1st and 2nd doses of COVID-19 vaccine with those of patients with mild or severe COVID-19 [PDF]
Background/Aims Data comparing the antibody responses of different coronavirus disease 2019 (COVID-19) vaccine platforms according to dose with natural severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced antibody responses are ...
Hye Hee Cha+6 more
doaj +1 more source
Anti-SARS-CoV-2 antibody responses in convalescent plasma donors with varying severity of COVID-19 illness [PDF]
Background/Aim. Plasma containing a high titer of anti-SARS-CoV-2 antibodies, donated from individuals who recovered from COVID-19, has the potential to be used as initial therapy for patients who have been infected (passive immunization).
Grujić Jasmina+4 more
doaj +1 more source
Comparison of the rapidity of SARS-CoV-2 immune responses between primary and booster vaccination for COVID-19 [PDF]
Background/Aims The rapidity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific memory B or T cell response in vaccinated individuals is important for our understanding of immunopathogenesis of coronavirus disease 2019 (COVID-19 ...
Ji Yeun Kim+5 more
doaj +1 more source
Humoral response to viral vector COVID-19 vaccine in hemodialysis patients [PDF]
Background The coronavirus disease 2019 (COVID-19) vaccine is not readily available in many countries where dosing interval is spaced more than ideal. Patients with chronic kidney disease, especially those on maintenance hemodialysis, have a tendency for
Niranjan Raja+5 more
doaj +1 more source
Predicted Indirectly ReCognizable Human Leukocyte Antigen (HLA) Epitopes (PIRCHE) are known to be a significant risk factor for the development of donor HLA-specific antibodies after organ transplantation.
Matthias Niemann+8 more
doaj +1 more source
Therapies for Chronic Allograft Rejection
Remarkable advances have been made in the pathophysiology, diagnosis, and treatment of antibody-mediated rejection (ABMR) over the past decades, leading to improved graft outcomes.
Min Young Kim, Daniel C. Brennan
doaj +1 more source
Background and Objectives: The present study aims to analyze the complex patient/treating physician interaction at onset of botulinum toxin (BoNT) therapy in patients with idiopathic cervical dystonia (CD) and the influence of high initial doses on long ...
Harald Hefter+4 more
doaj +1 more source
The COVID-19 pandemic continues to be a worldwide health issue. Among hemodialysis (HD) patients, two-dose immunization schemes with mRNA vaccines have contributed to preventing severe COVID-19 cases; however, some have not produced a sufficient humoral ...
José Jesús Broseta+5 more
doaj +1 more source